Centene (CNC)
(Delayed Data from NYSE)
$57.46 USD
-1.22 (-2.08%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $57.43 -0.03 (-0.05%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$57.46 USD
-1.22 (-2.08%)
Updated Nov 15, 2024 04:00 PM ET
After-Market: $57.43 -0.03 (-0.05%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
Zacks News
Will Centene (CNC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Centene (CNC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights: Centene, Archer Daniels Midland, Spirit Airlines, Pinnacle West and Walmart
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Centene, Archer Daniels Midland, Spirit Airlines, Pinnacle West and Walmart
Recession Risk Hits 7-Year High: 5 Secure Picks
by Swarup Gupta
A Wall Street Journal poll estimates that there is a 25% chance of a recession occurring within the next 12 months.
Has Centene (CNC) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (CNC) Outperforming Other Medical Stocks This Year?
Is Centene (CNC) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina Renews Pact With CVS to Boost PBM Service Platform
by Zacks Equity Research
Molina (MOH) expands deal with CVS Caremark for Pharmacy Benefit Management services.
Is Centene (CNC) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Centene Unit Collaborates With RxAdvance for New PBM Platform
by Zacks Equity Research
Centene's (CNC) Mississippi unit partners RxAdvance for establishing a transformative pharmacy benefit management model.
Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?
by Sweta Killa
Healthcare took a hit recently on Johnson & Johnson news and a federal judge ruling. The rough trading also spread into the ETF world.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHMM
WellCare (WCG) Buys Aetna's Medicare Assets to Fuel Growth
by Zacks Equity Research
WellCare's (WCG) purchase of Medicare business of Aetna should lead to long-term growth.
Here's Why Humana (HUM) Stock Looks Attractive Right Now
by Zacks Equity Research
Favorable changes across the industry and Humana's (HUM) strong operating profitability poise it for solid growth.
Centene (CNC) Up 3.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Centene (CNC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Centene (CNC) closed the most recent trading day at $136, moving +0.1% from the previous trading session.
Why UnitedHealth (UNH) is an Attractive Stock to Own Now
by Zacks Equity Research
Medicaid expansion, upward revision in earnings guidance and inherent business strength make UnitedHealth (UNH) an attractive bet.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for JHMM
Centene (CNC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Centene (CNC) closed at $142.31 in the latest trading session, marking a -0.93% move from the prior day.
Centene (CNC) in Focus: Stock Moves 9.2% Higher
by Zacks Equity Research
Centene (CNC) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Humana's (HUM) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Humana Inc.'s (HUM) Q3 earnings gain from Medicare Advantage enrollment, operational efficiency and lower impatient medical utilization
Tenet Healthcare's (THC) Q3 Earnings Beat, Increase Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter earnings benefit on the back of USPI and Conifer Segments.
MEDNAX (MD) Q3 Earnings Fall Short of Estimates, Rise Y/Y
by Zacks Equity Research
MEDNAX's (MD) Q3 earnings grow on the back of the company's operational efficiency as well as its various growth initiatives.
Ensign Group's (ENSG) Q3 Earnings Beat Mark, Increase Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) Q3 results gain from solid segmental performances.
Teladoc (TDOC) Q3 Loss Lower Than Estimates, Revenues Beat
by Zacks Equity Research
Teladoc's (TDOC) Q3 results show lower losses, revenues gain from increase in membership and patient visits.
Molina Healthcare's (MOH) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q3 earnings beat on the back of an effective performance management and a margin recovery plan.
Cigna (CI) Q3 Earnings & Revenues Beat, Guidance Up
by Zacks Equity Research
Cigna (CI) Q3 earnings gain on revenue and membership growth.